Celgene’s Fedratinib Given FDA Priority Review for New Drug Application in Myelofibrosis

PV Reporter was first to break the news on the Expanded Access Program for Fedratinib for Myelofibrosis Patients on November 16th, 2018. The next logical step for Celgene was filing for New Drug Application – Granted by the FDA on March 5th, 2019 Celgene Corporation announced today the U.S. Food and Drug Administration has accepted […]

Breaking news on Celgene’s Fedratinib for Myelofibrosis patients!

Breaking news on Fedratinib by Celgene, expanded use program for myelofibrosis patients

by David Wallace Fedratinib by Celgene, offered on Expanded Access Program (EAP) for Myelofibrosis Patients This is hot off the press!  So hot, that no one has covered it until now – brought to you by PV Reporter.  I knew after combing through the ASH (American Society of Hematology) abstracts that something was missing.  That […]

error: Content is protected !
Malcare WordPress Security